Genomic Landscape and Molecular Risk in Patients with Advanced Myelofibrosis Treated within the Multicenter Phase Ib/II MPNSG0212 (POMINC) Trial

▪ Introduction: Mutations (muts) in JAK2, MPL, and CALR are genetic hallmarks in myeloproliferative neoplasms such as myelofibrosis (MF). Prognostication in MF is predominantly based on clinical parameters according to the Dynamic International Prognostic Scoring System (DIPSS). However, gene mutati...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2021-11, Vol.138 (Supplement 1), p.4637-4637
Hauptverfasser:	Panina, Ekaterina, Koschmieder, Steffen, Heidel, Florian H., Hochhaus, Andreas, Hebart, Holger, Isfort, Susanne, Rücker, Frank G., Reiter, Andreas, Bangerter, Markus, Waller, Cornelius, Scheid, Christoph, Wolleschak, Denise, Goethert, Joachim R., Schafhausen, Philippe, Kindler, Thomas, Radsak, Markus P., Gattermann, Norbert, Möhle, Robert, von Bubnoff, Nikolas, Brümmendorf, Tim H, Döhner, Hartmut, Griesshammer, Martin, Stegelmann, Frank, Döhner, Konstanze
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!